TCM
CANO

Tuttle Capital Management’s Cano Health, Inc. CANO Stock Holding History

Tuttle Capital Management’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-101
Closed -$64K – 122
2022
Q1 		$64K Sell
101
-47
-32% -$29.6K 0.16% 81
2021
Q4 		$132K Buy
+148
New +$156K 0.2% 90

Other funds holding CANO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tuttle Capital Management's CANO Position: Q2 2022 in Review

Tuttle Capital Management sold out of Cano Health, Inc. (CANO) in Q2 2022, closing a stake of 101 shares — an estimated $64K sold.

Tuttle Capital Management first reported a position in CANO in Q4 2021 and held it in 2 quarters. The position peaked at $132K in Q4 2021. 145 funds tracked by Wall St. Rank hold CANO as of Q2 2022.

  • Tuttle Capital Management reported no remaining Cano Health, Inc. position as of Q2 2022 after selling out during the quarter.
  • Tuttle Capital Management sold 101 Cano Health, Inc. shares in Q2 2022, an estimated $64K.
  • Tuttle Capital Management first reported a position in Cano Health, Inc. in Q4 2021 and held it in 2 quarters.
  • Tuttle Capital Management's Cano Health, Inc. position peaked at $132K in Q4 2021.
  • 145 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2022.

Based on Tuttle Capital Management's 13F filing for Q2 2022, filed 3 Aug 2022.